BioLineRx (BLRX) Cash from Financing Activities (2013 - 2026)
BioLineRx (BLRX) reported Cash from Financing Activities of -$1.14 million for the quarter ended Jun 30, 2026, compared with $1.6 million a year earlier.
BioLineRx (BLRX) Cash from Financing Activities (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, BioLineRx's Cash from Financing Activities came in at -$4.49 million; for the year ended Dec 31, 2025, it came in at $8.88 million, down 57.0% from the prior year.
- Cash from Financing Activities has a five-year compound annual growth rate of -13.0% (years ended Dec 2020 to Dec 2025).
- By year, Cash from Financing Activities came in at $20.66 million in the year ended Dec 31, 2024 (+37.2%), $15.06 million in the year ended Dec 31, 2023 (-26.3%), $20.44 million in the year ended Dec 31, 2022 (-64.6%) and $57.75 million in the year ended Dec 31, 2021 (+223.2%).
- Five-year quarterly Cash from Financing Activities spans a low of -$1.25 million in the quarter ended Dec 31, 2025 and a high of $23.88 million in the quarter ended Jun 30, 2024.
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at -$1.18 million (quarter ended Mar 31, 2026), -$1.25 million (quarter ended Dec 31, 2025) and -$916,000 (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | BioLineRx | 6.14 Bn | 6.14 Bn | 235,000.00 | -1.14 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.14 Mn |
| Mar 31, 2026 | -1.18 Mn |
| Dec 31, 2025 | -1.25 Mn |
| Sep 30, 2025 | -916,000.00 |
| Jun 30, 2025 | 1.60 Mn |
| Mar 31, 2025 | 9.45 Mn |
| Dec 31, 2024 | -1.11 Mn |
| Sep 30, 2024 | -1.22 Mn |
| Jun 30, 2024 | 23.88 Mn |
| Mar 31, 2024 | -894,000.00 |
| Dec 31, 2023 | 11.74 Mn |
| Sep 30, 2023 | 3.50 Mn |
| Jun 30, 2023 | -134,000.00 |
| Mar 31, 2023 | -49,000.00 |
| Dec 31, 2022 | -647,000.00 |
| Sep 30, 2022 | 22.72 Mn |
| Jun 30, 2022 | -689,000.00 |
| Mar 31, 2022 | -943,000.00 |
| Dec 31, 2021 | 174,000.00 |
| Sep 30, 2021 | 1.58 Mn |
BioLineRx Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=BLRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();